Overview
- Health Minister Mark Butler asked the House health committee to open the inquiry after a government letter requested the probe, with consultation hearings due to start in late November and a final report expected by mid‑2027.
- Regulators report a sharp rise in unapproved peptide imports, compounding, supply and advertising driven by telehealth services and social media promotion, prompting the TGA to warn many products have not been assessed for safety or quality.
- Official data show hospital presentations linked to unapproved peptides have surged, with NSW Health reporting monthly cases climbing from five in July 2025 to 217 in September 2026 and the Poisons Information Centre logging hundreds of calls earlier this year.
- A Victorian coroner concluded the 2025 death of actor Richard Norton was triggered by an injection of unapproved peptides, and doctors have reported severe reactions including anaphylaxis and oesophageal injury in other patients.
- The inquiry will probe prescribing patterns, off‑label use, platform and telehealth responsibilities, consumer demand and sport integrity risks, and its recommendations could lead to tighter controls on prescribing, advertising, importing or online supply.